As of 30 Sep 2025, 139 institutional investors reported holding 45,852,231 shares of Humacyte, Inc. - COM (HUMA).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 229,024 | $227,516 | -$75,533 | $0.96 | 17 |
| 2025 Q3 | 45,852,231 | $79,792,130 | -$20,565,959 | $1.74 | 139 |
| 2025 Q2 | 56,964,566 | $119,040,607 | -$1,729,485 | $2.09 | 155 |
| 2025 Q1 | 60,715,449 | $103,532,553 | +$24,167,009 | $1.70 | 162 |
| 2024 Q4 | 42,106,165 | $212,715,890 | +$30,515,138 | $5.05 | 161 |
| 2024 Q3 | 35,792,230 | $194,660,626 | +$23,757,191 | $5.44 | 143 |
| 2024 Q2 | 31,200,014 | $149,783,918 | +$47,689,218 | $4.80 | 120 |
| 2024 Q1 | 23,275,197 | $72,382,833 | +$17,071,734 | $3.11 | 95 |
| 2023 Q4 | 17,820,871 | $50,656,070 | +$3,312,296 | $2.84 | 87 |
| 2023 Q3 | 16,610,977 | $48,671,458 | +$5,715,520 | $2.93 | 83 |
| 2023 Q2 | 14,729,897 | $42,225,781 | +$7,517,496 | $2.86 | 75 |
| 2023 Q1 | 12,062,725 | $37,417,372 | +$154,698 | $3.09 | 68 |
| 2022 Q4 | 11,918,522 | $25,143,027 | -$3,006,763 | $2.11 | 71 |
| 2022 Q3 | 11,840,854 | $38,602,556 | -$5,136,200 | $3.26 | 68 |
| 2022 Q2 | 13,437,579 | $43,130,190 | +$8,049,232 | $3.21 | 75 |
| 2022 Q1 | 10,487,756 | $73,993,016 | +$6,152,869 | $7.06 | 69 |
| 2021 Q4 | 9,522,696 | $69,016,600 | +$7,310,797 | $7.25 | 58 |
| 2021 Q3 | 4,907,194 | $56,957,000 | +$56,946,000 | $11.61 | 31 |